We need to pursue GMP principles and report nearly all that we do to ensure that patients will get safe and effectual medicines. We are assessed normally by different experts, and we generally should be “tuned in” with respect to the best available in the market.
Keeping our production network running easily requires a lot of strategies and contingencies: Do we need new machines? More experts? Task another procedure line? Or on the other hand shut down an old one? It’s tied in with identifying with a consistently changing world and conditions.
This relates specifically to the Adamjees, values like, development, innovation and versatility, and it fits great with my very own impression of which key components are the most essential so as to remain in business and improve the environment.
FAROOQ HAMIRANI, Managing Director (APL)